This section of the website is for UK healthcare professionals only. If you are not a healthcare professional, please click here.
This section of the website is for UK healthcare professionals only. If you are not a healthcare professional, please click here.

Training and Resources

Prescribing Information (Great Britain) & Prescribing Information (Northern Ireland) [External links]

KEYTRUDA® (pembrolizumab) in adjuvant renal cell carcinoma (RCC)

 

For more information about KEYTRUDA in adjuvant RCC:

Visit the product page

KEYTRUDA in advanced renal cell carcinoma (aRCC)

 

For more information about KEYTRUDA in advanced RCC:

Visit the product page

Supporting documentation

Prescribing Information (Great Britain) & Prescribing Information (Northern Ireland)
By clicking the links above you will leave the MSD Connect website and be taken to the emc PI portal website

GB-RCC-00372 | Date of Preparation: May 2022